Hyderabad: ProPharma, a global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, has officially inaugurated its new office in Hyderabad, India.
The announcement highlights ProPharma’s growing footprint as the company continues to scale its global capabilities.
ProPharma Expands Presence in Hyderabad’s Mindspace Technology Hub
The new ProPharma office is strategically located in Mindspace, the core of Hyderabad’s HITEC City/Madhapur technology corridor, placing the company among top Global Capability Centers (GCCs) in the pharmaceutical sector.
Also Read: Pharma Exports Near USD 30 Billion as India Strengthens Biotech and MedTech Ecosystem
Mindspace is also the first commercial business park in Hyderabad to secure a Gold rating from the Indian Green Building Council (IGBC).
Workforce Capacity and Innovation Culture
The Hyderabad expansion supports ProPharma’s growth trajectory by creating additional capacity for talent across regulatory, clinical, and compliance service lines.
The new facility features open, collaborative workspaces designed to foster innovation, productivity, and team connection. More than 70 employees participated in the inaugural event celebrating the company’s continued progress in India.
“This milestone represents an important step forward in the company’s global expansion,” noted Jason DeGoes, President, ProPharma.
“Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for clients around the world and reflects our commitment to building an exceptional environment for our teams.”
Echoing this sentiment, Pavan Hemadri, Director of Business Operations, ProPharma, added, “We’re proud to establish a world-class workspace in Hyderabad – one designed to foster creativity, efficiency, and collaboration. This move enhances our ability to attract top local talent and better serve our clients across key service domains.”
Also Read: Akums Partners with Government of Zambia to Establish Pharmaceutical Manufacturing Facility
Long-Term Commitment to India
The state-of-the-art Hyderabad office underscores the company’s sustained investment in India as a critical hub supporting its global operations.
With modern infrastructure and a culture aligned to innovation and operational excellence, the new facility plays a pivotal role in the company’s long-term growth plans.
